Leukemia pill shows promise - MSNewsNow.com - Jackson, MS

Leukemia pill shows promise

Posted: Updated:
  • HealthMore>>

  • FDA to propose e-cigarette regulations

    FDA to propose e-cigarette regulations

    © FDA© FDA
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
  • People seek out health info when famous person dies

    People seek out health info when famous person dies

    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
  • 1 in 13 U.S. schoolkids takes psych meds

    1 in 13 U.S. schoolkids takes psych meds

    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
JACKSON, MS (Mississippi News Now) -

A new pill is transforming the lives of some patients with aggressive leukemia -- many of whom are still alive years after they were told they had a few months to live.

In early-stage clinical trials, the drug Ibrutinib (ih-broo-tih-nib) prevented a relapse of C-L-L, a common form of leukemia, in seventy-five percent of patients over a two-year period. C-L-L typically affects older adults, and often doesn't require treatment.

For those who do need therapy, the options are chemotherapy or antibody treatment.

This drug targets a protein that cancer cells need to survive. It leaves other healthy cells alone, so patients report significantly fewer side effects.

It was also shown to be effective against M-L-L, a less common but very aggressive form of leukemia.

Cancer doctors say they are encouraged by the results, and believe this drug will change the way they treat these forms of the disease.

Ibrutinib has not been approved by the FDA. All of the patients in the studies had tried several other treatments and had not responded.

Outside experts say more studies are needed to see how the drug should be used -- and if there are any long-term side effects.

- Studies published in the New England Journal of Medicine.
- Studies conducted at MD Anderson Cancer Center and Ohio State's Comprehensive Cancer Center.

Copyright 2013 MSNewsNow. All rights reserved.

Powered by WorldNow